Genetic Technologies announces the global launch of the geneType Risk Assessment portfolio on our wholly owned EasyDNA platform currently selling in 42 countries, setting the stage for the potential significant expansion of the Company’s current A$7.5m annual revenues. This expansion allows the Company to promote and sell its most powerful geneType innovation on its most profitable channel to realise more than 70% gross margin. This key step change in conjunction with the Company’s structural reset will reduce cash burn to under A$200k per month from the previous A$800k, driving the Company towards its profitability target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GENE:
- Genetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platform
- Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on August 15
- Genetic Technologies intends to transition to capital light operations model
- Genetic Technologies Strategic Restructure Driving USA Sales Growth
- Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary